Literature DB >> 34999945

The lexicon for periprosthetic bone loss versus osteolysis after cervical disc arthroplasty: a systematic review.

Jenna M Wahbeh1,2, Sang-Hyun Park1,3, Patricia Campbell1,3, Edward Ebramzadeh1,3, Sophia N Sangiorgio4,5,6.   

Abstract

BACKGROUND: Periprosthetic bone loss is a common observation following arthroplasty. Recognizing and understanding the nature of bone loss is vital as it determines the subsequent performance of the device and the overall outcome. Despite its significance, the term "bone loss" is often misused to describe inflammatory osteolysis, a complication with vastly different clinical outcomes and treatment plans. Therefore, the goal of this review was to report major findings related to vertebral radiographic bone changes around cervical disc replacements, mitigate discrepancies in clinical reports by introducing uniform terminology to the field, and establish a precedence that can be used to identify the important nuances between these distinct complications.
METHODS: A systematic review of the literature was conducted following PRISMA guidelines, using the keywords "cervical," "disc replacement," "osteolysis," "bone loss," "radiograph," and "complications." A total of 23 articles met the inclusion criteria with the majority being retrospective or case reports.
RESULTS: Fourteen studies reported periprosthetic osteolysis in a total of 46 patients with onset ranging from 15-96 months after the index procedure. Reported causes included: metal hypersensitivity, infection, mechanical failure, and wear debris. Osteolysis was generally progressive and led to reoperation. Nine articles reported non-inflammatory bone loss in 527 patients (52.5%), typically within 3-6 months following implantation. The reported causes included: micromotion, stress shielding, and interrupted blood supply. With one exception, bone loss was reported to be non-progressive and had no effect on clinical outcome measures.
CONCLUSIONS: Non-progressive, early onset bone loss is a common finding after CDA and typically does not affect the reported short-term pain scores or lead to early revision. By contrast, osteolysis was less common, presenting more than a year post-operative and often accompanied by additional complications, leading to revision surgery. A greater understanding of the clinical significance is limited by the lack of long-term studies, inconsistent terminology, and infrequent use of histology and explant analyses. Uniform reporting and adoption of consistent terminology can mitigate some of these limitations. Executing these actionable items is critical to assess device performance and the risk of revision. LEVEL OF EVIDENCE IV: Diagnostic: individual cross-sectional studies with consistently applied reference standard and blinding.
© 2022. The Author(s).

Entities:  

Keywords:  Bone loss; Cervical disc replacement; Osteolysis; Periprosthetic bone changes; Radiographic outcome

Mesh:

Year:  2022        PMID: 34999945     DOI: 10.1007/s00586-021-07092-9

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  39 in total

1.  Early Polyethylene Failure in a Modern Total Hip Prosthesis: A Note of Caution.

Authors:  W Christian Thomas; Hari K Parvataneni; Richard G Vlasak; Chancellor F Gray
Journal:  J Arthroplasty       Date:  2020-01-03       Impact factor: 4.757

2.  Periprosthetic Bone Mineral Density Around Uncemented Titanium Stems in the Second and Third Decade After Total Hip Arthroplasty: A DXA Study After 12, 17 and 21 Years.

Authors:  David S Peitgen; Moritz M Innmann; Christian Merle; Tobias Gotterbarm; Babak Moradi; Marcus R Streit
Journal:  Calcif Tissue Int       Date:  2018-06-01       Impact factor: 4.333

3.  Surgical experience with an implanted artificial cervical joint.

Authors:  B H Cummins; J T Robertson; S S Gill
Journal:  J Neurosurg       Date:  1998-06       Impact factor: 5.115

4.  Comparable Stability of Cemented vs Press-Fit Placed Stems in Revision Total Knee Arthroplasty With Mild to Moderate Bone Loss: 6.5-Year Results From a Randomized Controlled Trial With Radiostereometric Analysis.

Authors:  Nienke M Kosse; Gijs G van Hellemondt; Ate B Wymenga; Petra J C Heesterbeek
Journal:  J Arthroplasty       Date:  2016-07-14       Impact factor: 4.757

5.  Cervical artificial disc replacement with ProDisc-C: clinical and radiographic outcomes with long-term follow-up.

Authors:  Gregory M Malham; Rhiannon M Parker; Ngaire J Ellis; Philip G Chan; Dinesh Varma
Journal:  J Clin Neurosci       Date:  2013-11-15       Impact factor: 1.961

6.  Cervical disc arthroplasty: 10-year outcomes of the Prestige LP cervical disc at a single level.

Authors:  Matthew F Gornet; J Kenneth Burkus; Mark E Shaffrey; Francine W Schranck; Anne G Copay
Journal:  J Neurosurg Spine       Date:  2019-05-10

7.  Artificial disc replacement versus fusion in patients with cervical degenerative disc disease and radiculopathy: a randomized controlled trial with 5-year outcomes.

Authors:  Anna MacDowall; Nuno Canto Moreira; Catarina Marques; Martin Skeppholm; Lars Lindhagen; Yohan Robinson; Håkan Löfgren; Karl Michaëlsson; Claes Olerud
Journal:  J Neurosurg Spine       Date:  2019-01-11

8.  Cervical Disc Arthroplasty with Prestige LP Disc Versus Anterior Cervical Discectomy and Fusion: Seven-Year Outcomes.

Authors:  Matthew F Gornet; J Kenneth Burkus; Mark E Shaffrey; Hui Nian; Frank E Harrell
Journal:  Int J Spine Surg       Date:  2016-06-22

9.  Clinical and radiological outcome at 10 years of follow-up after total cervical disc replacement.

Authors:  Christoph Mehren; Franziska Heider; Christoph J Siepe; Bernhard Zillner; Ralph Kothe; Andreas Korge; H Michael Mayer
Journal:  Eur Spine J       Date:  2017-07-04       Impact factor: 3.134

10.  Clinical and radiographic outcomes of cervical disc arthroplasty with Prestige-LP Disc: a minimum 6-year follow-up study.

Authors:  Junfeng Zeng; Hao Liu; Xin Rong; Beiyu Wang; Yi Yang; Xinlin Gao; Tingkui Wu; Ying Hong
Journal:  BMC Musculoskelet Disord       Date:  2018-08-07       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.